Advertisement

Reactions Weekly

, Volume 1735, Issue 1, pp 55–55 | Cite as

Bevacizumab

Interstitial pneumonia: case report
Case report
  • 5 Downloads

Reference

  1. Xing P, et al. Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancer. Thoracic Cancer 9: 1716-1724, No. 12, Dec 2018. Available from: URL: http://doi.org/10.1111/1759-7714.12886 -ChinaCrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations